| Code | 0208D | ||||||||||
| MA number | 88/0003/19-S | ||||||||||
| Product Form: | cps dur 1x37-7400 MBq (liek.PP) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Narodowe Centrum Badań Jądrowych, Poland | ||||||||||
| Therapeutic Class: | 88 - RADIOPHARMACA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 21 dní | ||||||||||
| Container: | container PP | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 22.01.2019 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Iodopol_02.2025.pdf
|
| SPC: |
SPC_Iodopol_02.2025.pdf
|
| Safety feature | No |
| Data update: | 12.01.2024 |
